MedPath

Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media

Completed
Conditions
Otitis Media
Otitis Media With Effusion
Pneumococcal Infections
Registration Number
NCT00195611
Lead Sponsor
Wyeth is now a wholly owned subsidiary of Pfizer
Brief Summary

The aim of this study is to assess in France the impact of Prevenar on the possible evolution of the pneumococcal serotypes distribution and antibiotic resistance in NP samples of children with AOM.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3293
Inclusion Criteria
  • Infants aged from 6 to 24 months
  • Presenting with AOM (ear infection)
  • Patients must not have received any antibiotic therapy within the past 7 days.

Other inclusion applies.

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath